# TRYNGOLZA

NDC: 71860-101
Generic name: olezarsen sodium
Labeler / Manufacturer: Ionis Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20241219

FDA application: NDA218614

## Active ingredients

- OLEZARSEN SODIUM: 80 mg/.8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71860-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71860-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0f51aa8e-8475-8cf9-e063-6394a90a6848